Greatmark Investment Partners Has Cut Its Anthem (ANTM) Stake; Laboratory Of America Holdings (LH) Sentiment Is 1.2

April 24, 2018 - By Michael Collier

Laboratory Corporation of America Holdings (NYSE:LH) Logo

Greatmark Investment Partners Inc decreased Anthem Inc (ANTM) stake by 7.6% reported in 2017Q4 SEC filing. Greatmark Investment Partners Inc sold 1,387 shares as Anthem Inc (ANTM)’s stock declined 2.73%. The Greatmark Investment Partners Inc holds 16,852 shares with $3.79 million value, down from 18,239 last quarter. Anthem Inc now has $58.13 billion valuation. The stock increased 0.50% or $1.13 during the last trading session, reaching $227.2. About 1.07M shares traded. Anthem, Inc. (NYSE:ANTM) has risen 35.30% since April 24, 2017 and is uptrending. It has outperformed by 23.75% the S&P500.

Laboratory Corp Of America Holdings (LH) investors sentiment increased to 1.2 in 2017 Q4. It’s up 0.30, from 0.9 in 2017Q3. The ratio improved, as 293 investment managers increased and opened new positions, while 245 sold and decreased stock positions in Laboratory Corp Of America Holdings. The investment managers in our database now have: 91.47 million shares, down from 91.79 million shares in 2017Q3. Also, the number of investment managers holding Laboratory Corp Of America Holdings in top ten positions decreased from 14 to 13 for a decrease of 1. Sold All: 36 Reduced: 209 Increased: 220 New Position: 73.

Since January 1, 0001, it had 0 insider buys, and 5 sales for $10.55 million activity.

The stock increased 0.88% or $1.45 during the last trading session, reaching $166.62. About 662,111 shares traded. Laboratory Corporation of America Holdings (LH) has risen 14.17% since April 24, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Veritas Investment Management Llp holds 6.79% of its portfolio in Laboratory Corporation of America Holdings for 307,591 shares. Bridger Management Llc owns 633,162 shares or 6.67% of their US portfolio. Moreover, Healthinvest Partners Ab has 5.99% invested in the company for 17,800 shares. The New York-based Healthcor Management L.P. has invested 5.71% in the stock. Allen Investment Management Llc, a New York-based fund reported 769,875 shares.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $17.00 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 13.65 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on April, 25 before the open. They expect $2.64 EPS, up 18.92% or $0.42 from last year’s $2.22 per share. LH’s profit will be $269.28M for 15.78 P/E if the $2.64 EPS becomes a reality. After $2.45 actual EPS reported by Laboratory Corporation of America Holdings for the previous quarter, Wall Street now forecasts 7.76% EPS growth.

Greatmark Investment Partners Inc increased Lowe’s Companies Inc (NYSE:LOW) stake by 22,645 shares to 41,905 valued at $3.90M in 2017Q4. It also upped Royal Dutch Shell Plc stake by 39,300 shares and now owns 40,500 shares. Alps Etf Tr (AMLP) was raised too.

Among 24 analysts covering Anthem Inc (NYSE:ANTM), 16 have Buy rating, 0 Sell and 8 Hold. Therefore 67% are positive. Anthem Inc had 75 analyst reports since July 27, 2015 according to SRatingsIntel. As per Friday, March 9, the company rating was maintained by Leerink Swann. On Monday, April 4 the stock rating was maintained by Leerink Swann with “Outperform”. FBR Capital maintained it with “Mkt Perform” rating and $162 target in Thursday, October 29 report. The rating was maintained by Bernstein on Thursday, January 25 with “Buy”. As per Wednesday, January 3, the company rating was initiated by Goldman Sachs. Cowen & Co maintained the stock with “Buy” rating in Wednesday, September 20 report. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, July 30. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. The firm has “Neutral” rating by Sterne Agee CRT given on Tuesday, May 24. The rating was maintained by Cantor Fitzgerald with “Buy” on Thursday, January 18.

Analysts await Anthem, Inc. (NYSE:ANTM) to report earnings on April, 25 before the open. They expect $4.93 earnings per share, up 5.34% or $0.25 from last year’s $4.68 per share. ANTM’s profit will be $1.26 billion for 11.52 P/E if the $4.93 EPS becomes a reality. After $1.29 actual earnings per share reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts 282.17% EPS growth.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: